Modag
Phase 2Breakthrough instead of borders.Our aim is to give patients with neurodegenerative diseases new hope and create opportunities to slow down, stop or even
Founded
2016
Focus
DiagnosticsSmall Molecules
About
Breakthrough instead of borders.Our aim is to give patients with neurodegenerative diseases new hope and create opportunities to slow down, stop or even
Funding History
2Total raised: $17.5M
Series A$15MBayern KapitalSep 15, 2022
Seed$2.5MHigh-Tech GründerfondsJun 15, 2021
Company Info
TypePrivate
Founded2016
LocationMunich, Germany
StagePhase 2
Contact
SIMILAR COMPANIES
300Microns
Pre-clinical · Munich
BetaSense
Pre-clinical · Berlin
AB Diagnostic Systems
Pre-clinical · Jena
bbi-biotech
Pre-clinical · Berlin
Mireca Medicines
Pre-clinical · Munich
Is this your company?
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile